RGS : Analysis & Opinions

  1. How Orgenesis Hopes To Cure Type 1 Diabetes

    November 3, 2014
    Orgenesis Inc's (OTC: personal touch. "As the father of a child who is living with Type 1 diabetes, I am personally motivated ...
  2. Progress Software Showing Signs Of Life In A Tough Market

    June 27, 2013
    Progress may be showing signs of the growth that investors badly need from its restructuring efforts
  3. VCA Antech: Generous C-Suite Compensation Provides Opportunity

    August 9, 2011
    VCA Antech's four named executive officers stand to make as much as $30.2 million when they retire. Surprisingly, this payout ...
  4. Progress Software Not in Regress (PRGS)

    March 22, 2007
    Investors would do well to educate themselves about Progress Software's interesting opportunities.
Trading Center